Gene mutation may influence MS drug safety in chinese patients
NCT ID NCT04410965
First seen Oct 31, 2025 · Last updated May 17, 2026 · Updated 27 times
Summary
This study looked at 82 Chinese adults with multiple sclerosis to see if a specific gene change (ABCG2 mutation) affects how the body processes the drug teriflunomide. Participants took the drug daily for 24 weeks, and researchers measured drug levels and tracked side effects like hair thinning, diarrhea, and liver changes. The goal was to better understand safety and drug exposure in this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number
China, China
Conditions
Explore the condition pages connected to this study.